Molecular analysis of Bcl-2 and cyclin Dl expression in differentially expressing estrogen receptor breast cancer MCF7, T47D and MDA-MB-468 cell lines treated with adriamycin

S., Kaabinejadian; S.H., Fouladdel; M., Ramezani; E., Azizi

S., Kaabinejadian; S.H., Fouladdel; M., Ramezani; E., Azizi.

DARU-Journal of Faculty of Pharmacy Tehran University of Medical Sciences. 2008; 16 (3): 182-188

in En | IMEMR | ID: emr-86105

Responsible library: EMRO

Subject(s)

Humans; Female; Breast Neoplasms/immunology; Breast Neoplasms/drug therapy; Cytogenetic Analysis; Genes, bcl-2/drug effects; Genes, bcl-2/genetics; Receptors, Estrogen; Doxorubicin; Cell Line, Tumor/classification; Cyclin D1/genetics; Reverse Transcriptase Polymerase Chain Reaction; Immunohistochemistry

Search on Google

Add to My VHL

XML

Index: IMEMR Main subject: Breast Neoplasms / Immunohistochemistry / Doxorubicin / Receptors, Estrogen / Genes, bcl-2 / Cyclin D1 / Reverse Transcriptase Polymerase Chain Reaction / Cytogenetic Analysis / Cell Line, Tumor Limits: Female / Humans Language: En Journal: J. Fac. Pharm. Tehran Univ. Med. Sci. Year: 2008

Search on Google

Add to My VHL

XML